{
  "actions": [
    {
      "acted_at": "2002-07-17", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2747-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "107", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2002-07-17", 
  "number": "2747", 
  "official_title": "A bill to provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries and for women diagnosed with breast cancer.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Breast Cancer Prescription Drug Fairness Act of 2002", 
  "sponsor": {
    "district": null, 
    "name": "Torricelli, Robert G.", 
    "state": "NJ", 
    "thomas_id": "01163", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2002-07-17", 
  "subjects": [
    "Ambulatory care", 
    "Breast cancer", 
    "Commerce", 
    "Congress", 
    "Congressional reporting requirements", 
    "Drug industry", 
    "Drug therapy", 
    "Drugs", 
    "Governmental investigations", 
    "Health", 
    "Hospices (Terminal care)", 
    "Life expectancy", 
    "Medicare", 
    "Pharmacies", 
    "Prescription pricing", 
    "Price discrimination", 
    "Social welfare", 
    "Terminally ill", 
    "Women", 
    "Women's health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2002-07-17", 
    "text": "Breast Cancer Prescription Drug Fairness Act of 2002 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Breast Cancer Prescription Drug Fairness Act of 2002", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries and for women diagnosed with breast cancer.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:47:38-05:00"
}